Drug Report History #142809

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that have changed between versions will be highlighted in yellow, and the changes will be clearly marked as updated.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow, and the change will be clearly marked as updated.

Field Version v18-EN Version v14-FR
Language English (Updated) French
Date Updated 2023-01-20 (Updated) 2022-06-03
Drug Identification Number 02304341 02304341
Brand name SODIUM CHLORIDE INJECTION USP 0.9% SODIUM CHLORIDE INJECTION USP 0.9%
Common or Proper name Sodium Chloride Injection USP Sodium Chloride Injection USP
Company Name TELIGENT OU TELIGENT OU
Ingredients SODIUM CHLORIDE SODIUM CHLORIDE
Strength(s) 9MG 9MG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 10 mL 10 mL
ATC code V07AB V07AB
ATC description ALL OTHER NON-THERAPEUTIC PRODUCTS ALL OTHER NON-THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-20 2021-07-20
Estimated end date 2022-08-03 (Updated) 2022-07-08
Actual end date 2022-08-03 (Updated)
Shortage status Resolved (Updated) Actual shortage
Tier 3 Status No (Updated) Yes
Company comments (Updated) Inventory released to market in May and June. Product will remain on allocation until resupply.
Health Canada comments